AIM
CLVS

Allen Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Allen Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,716
Closed -$305K – 219
2015
Q4 		$305K Hold
8,716
– – 0.03% 159
2015
Q3 		$802K Buy
8,716
+2,188
+34% +$189K 0.08% 108
2015
Q2 		$574K Hold
6,528
– – 0.05% 133
2015
Q1 		$485K Buy
+6,528
New +$461K 0.04% 150

Other funds holding CLVS

PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Allen Investment Management's CLVS Position: Q1 2016 in Review

Allen Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2016, closing a stake of 8,716 shares — an estimated $305K sold.

Allen Investment Management first reported a position in CLVS in Q1 2015 and held it in 4 quarters. The position peaked at $802K in Q3 2015. 135 funds tracked by Wall St. Rank hold CLVS as of Q1 2016.

  • Allen Investment Management reported no remaining Clovis Oncology, Inc. position as of Q1 2016 after selling out during the quarter.
  • Allen Investment Management sold 8,716 Clovis Oncology, Inc. shares in Q1 2016, an estimated $305K.
  • Allen Investment Management first reported a position in Clovis Oncology, Inc. in Q1 2015 and held it in 4 quarters.
  • Allen Investment Management's Clovis Oncology, Inc. position peaked at $802K in Q3 2015.
  • 135 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2016.

Based on Allen Investment Management's 13F filing for Q1 2016, filed 16 May 2016.